HomeCompareBWV vs PLD

BWV vs PLD: Dividend Comparison 2026

BWV yields 1109.88% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BWV wins by $47035730.79M in total portfolio value
10 years
BWV
BWV
● Live price
1109.88%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47035737.30M
Annual income
$39,954,235,177,691.26
Full BWV calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — BWV vs PLD

📍 BWV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBWVPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BWV + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BWV pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BWV
Annual income on $10K today (after 15% tax)
$94,339.62/yr
After 10yr DRIP, annual income (after tax)
$33,961,099,901,037.57/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, BWV beats the other by $33,961,095,433,066.81/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BWV + PLD for your $10,000?

BWV: 50%PLD: 50%
100% PLD50/50100% BWV
Portfolio after 10yr
$23517871.90M
Annual income
$19,977,120,217,063.72/yr
Blended yield
84.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

BWV
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Price Target
$4.00
+2119.8% upside vs current
Range: $4.00 — $4.00
Altman Z
-9.6
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BWV buys
0
PLD buys
0
No recent congressional trades found for BWV or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBWVPLD
Forward yield1109.88%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$47035737.30M$6.50M
Annual income after 10y$39,954,235,177,691.26$5,256,436.18
Total dividends collected$46502201.88M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$4.00$136.00

Year-by-year: BWV vs PLD ($10,000, DRIP)

YearBWV PortfolioBWV Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$121,688$110,987.79$11,255$555.24+$110.4KBWV
2$1,392,436$1,262,229.83$13,062$1,018.59+$1.38MBWV
3$14,988,323$13,498,416.50$15,903$1,926.67+$14.97MBWV
4$151,830,358$135,792,852.99$20,839$3,823.32+$151.81MBWV
5$1,448,037,323$1,285,578,839.42$30,464$8,166.08+$1448.01MBWV
6$13,008,119,121$11,458,719,185.11$52,054$19,457.30+$13008.07MBWV
7$110,121,340,317$96,202,652,857.66$109,886$54,188.93+$110121.23MBWV
8$878,962,312,032$761,132,477,893.38$304,030$186,451.18+$878962.01MBWV
9$6,618,226,279,560$5,677,736,605,685.80$1,166,125$840,813.32+$6618225.11MBWV
10$47,035,737,296,821$39,954,235,177,691.26$6,504,190$5,256,436.18+$47035730.79MBWV

BWV vs PLD: Complete Analysis 2026

BWVStock

Blue Water Vaccines, Inc., a biotechnology company, engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include BWV-101, an influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine. It also has other pipeline under preclinical development comprising BWV-201, a streptococcus pneumoniae induced acute otitis media vaccine program; BWV-301, a norovirus-rotavirus vaccine program; and BWV-302, a norovirus-malaria vaccine program. The company was incorporated in 2018 and is based in Cincinnati, Ohio.

Full BWV Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this BWV vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BWV vs SCHDBWV vs JEPIBWV vs OBWV vs KOBWV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.